Background Sinonasal neoplasms, whether benign and malignant, pose a significant
challenge to clinicians and represent a model area for multidisciplinary collaboration in …

Simple Summary SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare but locally
aggressive malignancy which usually presents very late with invasion into the orbits and …

Despite the progress of surgery, radiotherapy, and neoadjuvant chemotherapy, the
prognosis for advanced sinonasal cancers (SNCs) remains poor. In the era of precision …

Purpose Sinonasal undifferentiated carcinoma (SNUC) is a rare, aggressive malignancy of
the sinonasal cavity with poor prognosis and limited treatment options. To investigate the …

Studies reviewed here detail promising results of the most current and novel
characterization of SNUC, ITAC, and ONB genetic and molecular landscapes, which have …

Abstract Background Sinonasal Undifferentiated Carcinoma (SNUC) is a rare and
aggressive skull base tumor with poor survival and limited treatment options. To date …

Abstract Purpose of Review Sinonasal cancers are a heterogenous group of rare cancers for
which histopathological diagnosis can be very challenging and treatment options are limited …

Objectives Sinonasal undifferentiated carcinoma (SNUC) is a rare and aggressive disease
requiring multimodal treatment, and multiple new entities once included in the spectrum of …

Abstract Purpose of Review The sinonasal tract is home to a uniquely heterogenous
collection of malignant tumors. Human papillomavirus (HPV) has been detected in a number …

Objective This study aims to improve the understanding of SMARCB1 (integrase interactor
1)–deficient sinonasal carcinoma (SDSC) by analyzing its clinical features, treatment …